These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 6146281)
41. Arrhythmia suppression in postmyocardial infarction patients with special notation to cardiac arrhythmia suppression trial. Gheorghiade M; Goldstein S Prog Cardiovasc Dis; 1991; 33(4):213-8. PubMed ID: 1994455 [No Abstract] [Full Text] [Related]
42. [Can sudden cardiac death be prevented?]. Gross F MMW Munch Med Wochenschr; 1982 Jan; 124(1):27-31. PubMed ID: 6120453 [No Abstract] [Full Text] [Related]
43. Clinical efficacy of antiarrhythmic drugs in prevention of sudden coronary death. Winkle RA Ann N Y Acad Sci; 1982; 382():247-57. PubMed ID: 6979282 [No Abstract] [Full Text] [Related]
44. [Secondary prevention of myocardial infarct]. Kotsev G Vutr Boles; 1984; 23(2):55-9. PubMed ID: 6146228 [No Abstract] [Full Text] [Related]
45. Clinical experience with beta adrenergic blocking agents in myocardial ischaemia: a dilemma and a challenge. Baber NS Pharmacol Ther; 1981; 13(2):285-320. PubMed ID: 6116243 [No Abstract] [Full Text] [Related]
46. [Clinical use of beta-blocker an as antiarrhythmic agent]. Okazaki O; Akatsuka N Nihon Rinsho; 1996 Aug; 54(8):2117-24. PubMed ID: 8810786 [TBL] [Abstract][Full Text] [Related]
47. Cost-effectiveness of tests to assess the risk of sudden death after acute myocardial infarction. Hlatky MA; Owens DK J Am Coll Cardiol; 1998 Jun; 31(7):1490-2. PubMed ID: 9626824 [No Abstract] [Full Text] [Related]
48. Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction. Rotmensch HH; Vlasses PH; Ferguson RK Heart Lung; 1984 Jul; 13(4):366-71. PubMed ID: 6145686 [No Abstract] [Full Text] [Related]
49. [Dispersion of ventricular recovery time as a new marker of arrhythmogenic risk]. Ducceschi V; Sarubbi B; Esposito R; Manzo G; Mayer MS; Santangelo L; Iacono A Cardiologia; 1995 May; 40(5):355-60. PubMed ID: 8529247 [No Abstract] [Full Text] [Related]
51. Use of beta-adrenergic blocking agents after myocardial infarction. Frishman WH; Ruggio J; Furberg C Postgrad Med; 1985 Dec; 78(8):40-6, 49-53. PubMed ID: 2866506 [TBL] [Abstract][Full Text] [Related]
52. [Long-term therapy after an acute myocardial infarct]. Lengfelder W; Senges J Dtsch Med Wochenschr; 1992 Jul; 117(31-32):1201-4. PubMed ID: 1353722 [No Abstract] [Full Text] [Related]
53. [Effectiveness and comparative evaluation of various means of arrhythmia prophylaxis in acute period of myocardial infarction]. Leshchinskiĭ LA; Lazarenko VG Ter Arkh; 1979; 51(1):35-40. PubMed ID: 34898 [No Abstract] [Full Text] [Related]
57. [Perspectives of the preventive treatment of patients after myocardial infarction]. Chodorowski Z Pol Tyg Lek; 1984 Jan; 39(5):159-61. PubMed ID: 6146127 [No Abstract] [Full Text] [Related]
59. [Electric stability of the heart after myocardial infarction: role of anti-arrhythmia agents during postinfarction]. Sadoul N; Aliot E Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):773-80. PubMed ID: 1356328 [TBL] [Abstract][Full Text] [Related]
60. [Sudden death in coronary heart disease]. Hansteen V Tidsskr Nor Laegeforen; 1976 Oct; 96(28):1465-8. PubMed ID: 10640 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]